inclisiran
Commercial- Indications
- High Cholesterol
Company intelligence / Profile preview
Blackstone
New York, New York, United Statesblackstone.com ↗
- Ownership
- Public · BX
- Employees
- ~4000
- Development stage
- Commercial
01
Overview
Blackstone Life Sciences provides capital and operational expertise to advance late-stage medicines and technologies. It has helped bring over ~150 medicines to market with an ~85% Phase III success rate. Recent launches include Uniquity Bio with solrikitug for asthma/COPD entering Phase II trials. Investments span small molecules, biologics/mAbs, gene therapies, mRNA vaccines/therapies—often in partnership with leading pharma/biotech firms.
- Therapeutic areas
- PulmonologyCardiovascularOncology
- Modalities
- Small moleculeMonoclonal antibodyGene therapymRNA-based drugsBiologic
- Industry
- Investors
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Novartis (“Anthos Therapeutics” JV)Alnylam Pharmaceuticals (“inclisiran”)Moderna ($750M R&D partnership)Medtronic ($337M deal)Reata Pharmaceuticals ($350M deal)CMIC Holdings Co., Ltd. (~60% stake in leading Asian CRO as of May/June '25)
04
Financials
- Market cap
- $161.8B
- Total revenue
- $4.8B
- Enterprise value
- $173.4B
Beyond the preview
Go deeper on Blackstone.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Blackstone.